Session to update attendees on the promise of FHIR
The Fast Healthcare Interoperability Resources specification, known as FHIR, is quickly becoming a mature standard supporting content, workflow and physical access to data.
The latest release of the FHIR specification, expected in mid-March, will be a comparatively stable version that can be used, and the fourth version will be even more stable, says Wayne Kubick, chief technology officer at Health Level Seven International.
The standard can be implemented quickly and is easier to integrate with information systems and smartphones, according to Kubick. “It really is a different platform, the likes of which we haven’t seen before in the healthcare industry,” he adds.
During a session at HIMSS17, Kubick will walk through the promises and challenges of FHIR, including its importance to the pharmaceutical and life sciences industries, as well as to providers, payers and consumers. Insurers, for example, will be able to rely on higher quality data to support reimbursement levels.
FHIR presents data in a consistent format, a critical attribute as the industry moves further into value-based care focused on improving outcomes, Kubick explains. It will enable stakeholders to bring more and consistent data into the world of clinical research, making it easier to conduct randomized and pragmatic clinical trials and get a more accurate picture of using medical treatments in the real world, he contends.
Most drugs work with one out of three patients and in the precision medicine era we to better know why, he says. With FHIR, “We can do more with data than ever before. It’s really a new healthcare world.”
Consequently, Kubick will present multiple use cases on how FHIR can improve clinical and regulatory processes.
Session 37, “Setting Clinical Research on FHIR,” is scheduled at 1:30 p.m. on February 20 in Room 304A.